Saturday, May 26, 2012 7:49:10 PM
I was invested in a tech company (but have since sold) that voluntarily delisted to the pinks. I kept this company on my watch list and decided to check back with them to see how things were going.
Well .. I read an interesting article from a SeekingAlpha author who feels they voluntarily delisted in order to acquire shares.
The company is ZSTN.PK and here's a link to the article ..
http://seekingalpha.com/article/607191-chinese-rtos-covertly-going-private?source=yahoo
The first sentence of the 2nd paragraph is what caught my attention ..
"My hypothesis suggests that both of these companies are staying silent about taking themselves private so they can buy back shares at a much cheaper price."
This is a China tech company, which of course is suspect given the current perception of the sector but felt there was some overlap to ATRN in regards to the hypothesis of buying back shares via voluntarily delisting to the pinks. Also the fact the author talks about an investment company increasing their position since going pink.
I'm not saying ATRN is going private (or being bought out) but it seems (as this author's opinion suggests) there are advantages for "real" companies to voluntarily delist and be silent.
Take from this article what you will.
Recent PTIX News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 07:29:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 08:50:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 10:18:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 09:02:39 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/02/2023 08:29:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/13/2023 04:48:45 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:29:32 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM